Created at	Source	Raw Value	Validated value
March 19, 2021, 12:31 a.m.	usa	Immunogenicity index-seroconversion rates of neutralizing antibody against SARS-CoV-2;Safety index-incidence of adverse reactions within 7 days after each dose	Immunogenicity index-seroconversion rates of neutralizing antibody against SARS-CoV-2;Safety index-incidence of adverse reactions within 7 days after each dose